Its molecule is well known and already used in medicine. This is a major hope for people who experience debilitating headaches. On July 9, 2026, the French pharmaceutical laboratory Ipsen announced results which could mark a turning point in the treatment of migraine, a disease which affects around 11 million…

Few recent drug launches have scaled as quickly as Rezdiffra, and the company behind it, Madrigal Pharmaceuticals, has become a case study in what a first-in-disease approval can do for a single-product biotech. Madrigal built its business around resmetirom, sold as Rezdiffra, the first therapy cleared by the FDA for…

An athlete’s career does not end when the clock goes off, a race ends or the curtain comes down on a competition. Behind every sporting path there are skills, abilities and values ​​that can find space even beyond the competition field: discipline, pressure management, resilience, teamwork, ability to achieve goals.…